Cite
Interferon signalling contributes to therapy‐resistant prostate cancer progression
MLA
Amanda W. Dong, et al. “Interferon Signalling Contributes to Therapy‐resistant Prostate Cancer Progression.” Clinical and Translational Discovery, vol. 2, no. 3, Sept. 2022. EBSCOhost, https://doi.org/10.1002/ctd2.117.
APA
Amanda W. Dong, Artem Cherkasov, & Xuesen Dong. (2022). Interferon signalling contributes to therapy‐resistant prostate cancer progression. Clinical and Translational Discovery, 2(3). https://doi.org/10.1002/ctd2.117
Chicago
Amanda W. Dong, Artem Cherkasov, and Xuesen Dong. 2022. “Interferon Signalling Contributes to Therapy‐resistant Prostate Cancer Progression.” Clinical and Translational Discovery 2 (3). doi:10.1002/ctd2.117.